| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Peter J. Ghiloni last filed a Form 4 in March 2022, as Director at YCBD. Peter J. Ghiloni's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 310,000 shares of YCBD. Net of sales, the YCBD filings show accumulation of 150,000 shares.
Peter J. Ghiloni has 6 Form 4 filings on record from May 2019 to March 2022, all as Director at cbdMD (YCBD), 2019–2022.
The 11 reported transactions were 8 option or other derivative awards, 2 open-market purchases and 1 stock award.
Counted by filing, the open-market trades come to 2 purchases worth about $144K and no sales.
The largest open-market purchase was 125,000 shares of YCBD at an average $1.00 on January 14, 2020, about $125K.
Shares as reported in the last Form 4 for each company; the most recent is from March 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.